Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of local nasal immunotherapy using hypoallergenic birch pollen ointment in patients with pollen-food allergy syndrome: A preliminary study of five cases.
Komatsuzaki K, Otani Y, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Yorozu P, Hanazawa R, Hirakawa A, Murakami D, Miyazaki Y. Komatsuzaki K, et al. Among authors: sekino y. Allergol Int. 2024 Nov 11:S1323-8930(24)00123-0. doi: 10.1016/j.alit.2024.10.006. Online ahead of print. Allergol Int. 2024. PMID: 39532556 Free article. No abstract available.
Fully gapped pairing state in spin-triplet superconductor UTe2.
Suetsugu S, Shimomura M, Kamimura M, Asaba T, Asaeda H, Kosuge Y, Sekino Y, Ikemori S, Kasahara Y, Kohsaka Y, Lee M, Yanase Y, Sakai H, Opletal P, Tokiwa Y, Haga Y, Matsuda Y. Suetsugu S, et al. Among authors: sekino y. Sci Adv. 2024 Feb 9;10(6):eadk3772. doi: 10.1126/sciadv.adk3772. Epub 2024 Feb 7. Sci Adv. 2024. PMID: 38324692 Free PMC article.
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study.
Nagumo Y, Hattori K, Kimura T, Sekino Y, Naiki T, Kobayashi Y, Matsumoto T, Osawa T, Kita Y, Takemura M, Mathis BJ, Suzuki S, Tsuzuki T, Ishikawa H, Nishiyama H. Nagumo Y, et al. Among authors: sekino y. Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03774-X. doi: 10.1016/j.ijrobp.2024.12.019. Online ahead of print. Int J Radiat Oncol Biol Phys. 2025. PMID: 39755215
AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population.
Hinata N, Fujisawa M, Yamaguchi R, Katsura D, Kitano H, Sekino Y, Yoshioka K, Koike S, Odagaki Y, Ozawa Y, Aoki K, Miyauchi T, Watanabe S, Barber N, Elterman D, Afshar A, Saito K, Ide H, Horie S. Hinata N, et al. Among authors: sekino y. Int J Urol. 2024 Dec 13. doi: 10.1111/iju.15651. Online ahead of print. Int J Urol. 2024. PMID: 39670346
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG).
Sekino Y, Hishida T, Yoshioka H, Wakabayashi M, Mitome N, Shiono S, Kenmotsu H, Nosaki K, Aokage K, Horinouchi H, Fukuda H, Ohe Y, Watanabe SI; Lung Cancer Surgical Study Group (LCSSG) and the Lung Cancer Study Group (LCSG) of the Japan Clinical Oncology Group (JCOG). Sekino Y, et al. Jpn J Clin Oncol. 2024 Oct 23:hyae143. doi: 10.1093/jjco/hyae143. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39444315
Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study).
Kita R, Ito K, Machida R, Sekino Y, Nakamura N, Nakajima Y, Saito T, Imano N, Fukuda H, Ito Y, Mizowaki T; Japan Clinical Oncology Group Radiation Therapy Study Group. Kita R, et al. Among authors: sekino y. Jpn J Clin Oncol. 2024 Oct 21:hyae145. doi: 10.1093/jjco/hyae145. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39431960
384 results